Fiche centre
Beijing Tiantan Hospital, Capital Medical University
Beijing — China
Essais liés13clinical trials
VilleBeijinglocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07641998
Essais cliniques associés
13| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| HRS-4029 | Accident vasculaire cérébral | Phase 2 | NCT07739160 | The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients | RECRUITING |
| SEEG RF-TC | Épilepsie | Non applicable | NCT07923058 | SEEG-DRE — Clinical Trial of SEEG for Drug-resistant Epilepsy | NOT_YET_RECRUITING |
| Robot-assisted stereotactic hematoma aspiration plus intrahematoma tenecteplase | Accident vasculaire cérébral | Phase 1 | NCT07641998 | REPORT — Robot-Assisted Hematoma Evacuation With Intrahematoma Tenecteplase for Post-Reperfusion PH2 Hemorrhagic Transformation | NOT_YET_RECRUITING |
| Laser interstitial thermal therapy | Cancer | Non applicable | NCT07132203 | Magnetic Resonance-Guided Laser Interstitial Thermal Therapy for Brain Metastases Trial | COMPLETED |
| LVIVO-TaVec400 product | Myasthénie | Phase 1 | NCT07583030 | A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases | WITHDRAWN |
| Yangxue Qingnao Granules (Pills) | Migraine | À vérifier | NCT05334927 | CHAIRS — China HeadAche DIsorders RegiStry | RECRUITING |
| UX-GIP001 | Épilepsie | Phase 1 | NCT07572812 | A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy | RECRUITING |
| RP902 | Alzheimer | Phase 2 | NCT07579884 | To Evaluate the Safety and Efficacy of RP902 Tablets | RECRUITING |
| Nipocalimab | Myasthénie | Phase 3 | NCT04951622 | A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis | RECRUITING |
| filiform needling | Migraine | Non applicable | NCT07633522 | Fire Needling Plus Filiform Needling for Chronic Migraine With Comorbid Tension-Type Headache | NOT_YET_RECRUITING |
| [18F]-APN-1607 | Alzheimer | Phase 3 | NCT07752784 | Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem Brain Tissue Tau Pathology in Individuals With HV and MCI or AD. | ENROLLING_BY_INVITATION |
| TJ0113 200mg | Parkinson | Phase 3 | NCT07741045 | Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease | NOT_YET_RECRUITING |
| RC18 160mg | Myasthénie | Phase 2 | NCT04302103 | A Study of TACI（Transmembrane Activator and Calcium-modulator and Cyclophilin Ligand (CAML) Interactor）-Antibody Fusion Protein Injection (RC18) in Subjects With Systemic Myasthenia Gravis | COMPLETED |